These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37235572)

  • 1. Prevalence of psychological distress, quality of life, and satisfaction among patients and family members following comprehensive genomic profiling testing: Protocol of the Quality of life for Cancer genomics and Advanced Therapeutics (Q-CAT) study.
    Nishino M; Fujimori M; Koyama T; Hirata M; Tanabe N; Shimizu T; Yamamoto N; Uchitomi Y
    PLoS One; 2023; 18(5):e0283968. PubMed ID: 37235572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of psychological distress and associated factors among patients undergoing comprehensive genomic profiling testing: protocol for a multicentre, prospective, observational study.
    Matsuoka A; Fujimori M; Koyama T; Sato A; Mori K; Hirata M; Tanabe N; Nakachi K; Kato S; Okamoto H; Ogawa K; Komatsu H; Iwasaku M; Miyaji T; Uchitomi Y
    BMJ Open; 2023 Nov; 13(11):e072472. PubMed ID: 37996226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Return of comprehensive tumour genomic profiling results to advanced cancer patients: a qualitative study.
    Best MC; Bartley N; Napier CE; Fisher A; Ballinger ML; Thomas DM; Goldstein D; Tucker K; Biesecker BB; Butow P
    Support Care Cancer; 2022 Oct; 30(10):8201-8210. PubMed ID: 35809119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-world assessment of comprehensive genome profiling impact on clinical outcomes: A single-institution study in Japan.
    Kunimasa K; Sugimoto N; Yamasaki T; Kukita Y; Fujisawa F; Inoue T; Yamaguchi Y; Kitasaka M; Sakai D; Honma K; Wakamatsu T; Yamamoto S; Hayashi T; Mabuchi S; Okuno J; Kawamura T; Kai Y; Urabe M; Nishimura K
    Cancer Med; 2024 Sep; 13(18):e70249. PubMed ID: 39315676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Budget impact analysis of comprehensive genomic profiling for untreated advanced or recurrent solid cancers in Japan.
    Tang W; Hanada K; Motoo Y; Sakamaki H; Oda T; Furuta K; Abutani H; Ito S; Tsutani K
    J Med Econ; 2023; 26(1):614-626. PubMed ID: 37073487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Budget impact analysis of comprehensive genomic profiling in patients with advanced non-small cell lung cancer.
    Signorovitch J; Zhou Z; Ryan J; Anhorn R; Chawla A
    J Med Econ; 2019 Feb; 22(2):140-150. PubMed ID: 30430885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychological impact of comprehensive tumor genomic profiling results for advanced cancer patients.
    Butow PN; Best MC; Davies G; Schlub T; Napier CE; Bartley N; Ballinger ML; Juraskova I; Meiser B; Goldstein D; Biesecker B; Thomas DM;
    Patient Educ Couns; 2022 Jul; 105(7):2206-2216. PubMed ID: 35153126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-CAT: The National Datacenter for Cancer Genomic Medicine in Japan.
    Kohno T; Kato M; Kohsaka S; Sudo T; Tamai I; Shiraishi Y; Okuma Y; Ogasawara D; Suzuki T; Yoshida T; Mano H
    Cancer Discov; 2022 Nov; 12(11):2509-2515. PubMed ID: 36321305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The PiGeOn project: protocol for a longitudinal study examining psychosocial, behavioural and ethical issues and outcomes in cancer tumour genomic profiling.
    Best M; Newson AJ; Meiser B; Juraskova I; Goldstein D; Tucker K; Ballinger ML; Hess D; Schlub TE; Biesecker B; Vines R; Vines K; Thomas D; Young MA; Savard J; Jacobs C; Butow P
    BMC Cancer; 2018 Apr; 18(1):389. PubMed ID: 29621994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychological outcomes in advanced cancer patients after receiving genomic tumor profiling results.
    Vatter S; Schlub TE; Napier CE; Best MC; Bartley N; Juraskova I; Meiser B; Ballinger ML; Biesecker BB; Goldstein D; Thomas DM; Butow P;
    Health Psychol; 2022 Jun; 41(6):396-408. PubMed ID: 35604703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An approach for improvement of the accuracy of cancer gene panel testing.
    Imoto K; Yamamoto H; Ohkawa C; Shimada N; Ikuzawa R; Takeda H; Ohhara T; Kojima Y; Furuya N; Motoyoshi A; Migita O; Kuga A; Keira T; Wakamatsu H; Sato T; Oike N; Koike J; Yamano Y; Sunakawa Y
    Int J Clin Oncol; 2024 May; 29(5):571-581. PubMed ID: 38472663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Data-Sharing Systems of the Center for Cancer Genomics and Advanced Therapeutics(C-CAT)Repository Database and Expectation for the Future Medical Research and Development].
    Suzuki T
    Gan To Kagaku Ryoho; 2022 Nov; 49(11):1175-1182. PubMed ID: 36412016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The PiGeOn project: protocol of a longitudinal study examining psychosocial and ethical issues and outcomes in germline genomic sequencing for cancer.
    Best M; Newson AJ; Meiser B; Juraskova I; Goldstein D; Tucker K; Ballinger ML; Hess D; Schlub TE; Biesecker B; Vines R; Vines K; Thomas D; Young MA; Savard J; Jacobs C; Butow P
    BMC Cancer; 2018 Apr; 18(1):454. PubMed ID: 29685123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive genomic profiling and treatment patterns across ancestries in advanced prostate cancer: a large-scale retrospective analysis.
    Sivakumar S; Lee JK; Moore JA; Hopkins J; Newberg JY; Madison R; Graf R; Schrock AB; Kobetz E; Vince R; Franco I; Seldon C; Frampton GM; Mills J; Venstrom J; Mahal BA
    Lancet Digit Health; 2023 Jun; 5(6):e380-e389. PubMed ID: 37236698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges of Conducting Value Assessment for Comprehensive Genomic Profiling.
    Tarride JE; Gould T; Thomas DM
    Int J Technol Assess Health Care; 2022 Jun; 38(1):e57. PubMed ID: 35674123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical genomic profiling to identify actionable alterations for investigational therapies in patients with diverse sarcomas.
    Groisberg R; Hong DS; Holla V; Janku F; Piha-Paul S; Ravi V; Benjamin R; Kumar Patel S; Somaiah N; Conley A; Ali SM; Schrock AB; Ross JS; Stephens PJ; Miller VA; Sen S; Herzog C; Meric-Bernstam F; Subbiah V
    Oncotarget; 2017 Jun; 8(24):39254-39267. PubMed ID: 28424409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precision Oncology in Metastatic Uterine Cancer; Croatian First-Year Experience of the Comprehensive Genomic Profiling in Everyday Clinical Practice.
    Čerina D; Matković V; Katić K; Lovasić IB; Šeparović R; Canjko I; Jakšić B; Fröbe A; Pleština S; Bajić Ž; Vrdoljak E
    Pathol Oncol Res; 2021; 27():1609963. PubMed ID: 34646088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current Status and Future Direction of Cancer Genomic Medicine in Japan].
    Muto M
    Gan To Kagaku Ryoho; 2020 Feb; 47(2):197-202. PubMed ID: 32381946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germline sequencing for presumed germline pathogenic variants via tumor-only comprehensive genomic profiling.
    Kondo T; Yamamoto Y; Fukuyama K; Kanai M; Yamada A; Matsubara J; Quy PN; Yoshioka M; Yamada T; Minamiguchi S; Matsumoto S; Kosugi S; Muto M
    Int J Clin Oncol; 2022 Aug; 27(8):1256-1263. PubMed ID: 35567649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing Survival Outcomes for Advanced Cancer Patients Who Received Complex Genomic Profiling Using a Synthetic Control Arm.
    O'Haire S; Degeling K; Franchini F; Tran B; Luen SJ; Gaff C; Smith K; Fox S; Desai J; IJzerman M
    Target Oncol; 2022 Sep; 17(5):539-548. PubMed ID: 36063280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.